137 related articles for article (PubMed ID: 12749149)
1. [Myocardial revascularization in acute coronary syndrome without ST-segment elevation].
Hamon M
Rev Prat; 2003 Mar; 53(6):629-34. PubMed ID: 12749149
[TBL] [Abstract][Full Text] [Related]
2. API expert consensus document on management of ischemic heart disease.
Association of Physicians of India
J Assoc Physicians India; 2006 Jun; 54():469-80. PubMed ID: 16909697
[TBL] [Abstract][Full Text] [Related]
3. Management and outcome of patients with established coronary artery disease: the Euro Heart Survey on coronary revascularization.
Lenzen MJ; Boersma E; Bertrand ME; Maier W; Moris C; Piscione F; Sechtem U; Stahle E; Widimsky P; de Jaegere P; Scholte op Reimer WJ; Mercado N; Wijns W;
Eur Heart J; 2005 Jun; 26(12):1169-79. PubMed ID: 15802360
[TBL] [Abstract][Full Text] [Related]
4. Interpretation of new treatment guidelines for non-ST-segment elevation acute coronary syndromes: "ischemia-guided" versus "early invasive" strategies.
Boden WE
Minerva Cardioangiol; 2003 Oct; 51(5):447-61. PubMed ID: 14551515
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of enoxaparin compared with unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention in the Superior Yield of the New Strategy of Enoxaparin, Revascularization and Glycoprotein IIb/IIIa Inhibitors (SYNERGY) trial.
White HD; Kleiman NS; Mahaffey KW; Lokhnygina Y; Pieper KS; Chiswell K; Cohen M; Harrington RA; Chew DP; Petersen JL; Berdan LG; Aylward PE; Nessel CC; Ferguson JJ; Califf RM
Am Heart J; 2006 Dec; 152(6):1042-50. PubMed ID: 17161049
[TBL] [Abstract][Full Text] [Related]
6. Implications of upstream glycoprotein IIb/IIIa inhibition and coronary artery stenting in the invasive management of unstable angina/non-ST-elevation myocardial infarction: a comparison of the Thrombolysis In Myocardial Infarction (TIMI) IIIB trial and the Treat angina with Aggrastat and determine Cost of Therapy with Invasive or Conservative Strategy (TACTICS)-TIMI 18 trial.
Sabatine MS; Morrow DA; Giugliano RP; Murphy SA; Demopoulos LA; DiBattiste PM; Weintraub WS; McCabe CH; Antman EM; Cannon CP; Braunwald E
Circulation; 2004 Feb; 109(7):874-80. PubMed ID: 14757697
[TBL] [Abstract][Full Text] [Related]
7. [Clinical characteristics, in-hospital outcomes and predictors of in-hospital mortality in patients with acute coronary syndromes without persistent ST-segment elevation assigned to early invasive treatment strategy].
Szyguła-Jurkiewicz B; Wojnicz R; Trzeciak P; Niklewski T; Zembala M; Poloński L
Przegl Lek; 2005; 62(5):265-9. PubMed ID: 16334529
[TBL] [Abstract][Full Text] [Related]
8. Interactions between heparins, glycoprotein IIb/IIIa antagonists, and coronary intervention. The Global Registry of Acute Coronary Events (GRACE).
Brieger D; Van de Werf F; Avezum A; Montalescot G; Kennelly BM; Granger CB; Goodman SG; Dabbous OH; Agnelli G;
Am Heart J; 2007 Jun; 153(6):960-9. PubMed ID: 17540196
[TBL] [Abstract][Full Text] [Related]
9. [Prognosis after acute coronary syndrome. Lack of difference according to the sex].
Bounhoure JP; Farah B; Fajadet J; Marco J
Bull Acad Natl Med; 2004; 188(3):383-97; discussion 397-9. PubMed ID: 15584651
[TBL] [Abstract][Full Text] [Related]
10. [Medical treatment of acute coronary syndrome without ST-segment elevation].
Collet JP; Choussat R; Montalescot G
Rev Prat; 2003 Mar; 53(6):624-8. PubMed ID: 12749148
[TBL] [Abstract][Full Text] [Related]
11. [Acute coronary ischemic syndrome without ST elevation. Role of glycoprotein IIB/IIIA inhibitors and percutaneous coronary interventions].
Peña Duque MA
Arch Cardiol Mex; 2006; 76 Suppl 2():S249-51. PubMed ID: 17017111
[TBL] [Abstract][Full Text] [Related]
12. Balancing benefit against risk in the choice of therapy for coronary artery disease. Lesson from prospective, randomized, clinical trials of percutaneous coronary intervention and coronary artery bypass graft surgery.
Morrison DA; Sacks J
Minerva Cardioangiol; 2003 Oct; 51(5):585-97. PubMed ID: 14551526
[TBL] [Abstract][Full Text] [Related]
13. Early discharge is feasible following primary percutaneous coronary intervention with transradial stent implantation under platelet glycoprotein IIb/IIIa receptor blockade. Results of the AGGRASTENT Trial.
Dirksen MT; Ronner E; Laarman GJ; van Heerebeek L; Slagboom T; van der Wieken LR; van der Wouw PA; Kiemeneij F
J Invasive Cardiol; 2005 Oct; 17(10):512-7. PubMed ID: 16204742
[TBL] [Abstract][Full Text] [Related]
14. Platelet glycoprotein IIb/IIIa inhibitor therapy in non-ST segment elevation acute coronary syndromes.
Elmouchi DA; Bates ER
Minerva Cardioangiol; 2003 Oct; 51(5):547-60. PubMed ID: 14551523
[TBL] [Abstract][Full Text] [Related]
15. Tirofiban in acute coronary syndromes.
Menozzi A; Merlini PA; Ardissino D
Expert Rev Cardiovasc Ther; 2005 Mar; 3(2):193-206. PubMed ID: 15853593
[TBL] [Abstract][Full Text] [Related]
16. [Percutaneous and surgical revascularization in acute coronary syndromes without persistent ST segment elevation. One-year outcome of 361 patients assigned to early invasive strategy].
Szyguła-Jurkiewicz B; Wilczek K; Przybylski R; Pacholewicz J; Trzeciak P; Styn T; Zembala M; Poloński L
Przegl Lek; 2004; 61(12):1295-300. PubMed ID: 15850316
[TBL] [Abstract][Full Text] [Related]
17. The emerging role of platelet glycoprotein IIb/IIIa inhibitors in managing high-risk patients with non-ST segment elevation acute coronary syndromes.
Bolognese L
Curr Med Res Opin; 2007 Jun; 23(6):1217-26. PubMed ID: 17559721
[TBL] [Abstract][Full Text] [Related]
18. Characterization of myocardial infarction as an end point in two large trials of acute coronary syndromes.
Mahaffey KW; Roe MT; Kilaru R; French JK; Alexander JH; Berdan LG; Van De Werf F; Simoons ML; Weaver WD; White HD; Lincoff AM; Kleiman NS; Topol EJ; Harrington RA
Am J Cardiol; 2005 Jun; 95(12):1404-8. PubMed ID: 15950560
[TBL] [Abstract][Full Text] [Related]
19. Current percutaneous coronary intervention and coronary artery bypass grafting practices for three-vessel and left main coronary artery disease. Insights from the SYNTAX run-in phase.
Kappetein AP; Dawkins KD; Mohr FW; Morice MC; Mack MJ; Russell ME; Pomar J; Serruys PW
Eur J Cardiothorac Surg; 2006 Apr; 29(4):486-91. PubMed ID: 16497510
[TBL] [Abstract][Full Text] [Related]
20. [Percutaneous coronary interventions in elderly patients: clinical indications and adjunctive medical treatment. The Italian Drug Evaluation in Angioplasty (IDEA) study].
Bossi I; Piccaluga E; Scatturin M; Corvaja N; Pasquetto G; Steffanon L; Oberhollenzer R; Colombo P; Bolognese L; Savonitto S
G Ital Cardiol (Rome); 2006 Feb; 7(2):136-44. PubMed ID: 16532725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
